RepRegen
London · Founded 2006
About RepRegen
A spin-out from Imperial Innovations plc and headquartered within the Imperial College Incubator, RepRegen is poised to commercialize the initial product of its hard tissue repair and regeneration platform: StronBone™ Bone Graft Substitute. The Company's hard tissue platform is based on 'smart' bioceramics designed to be used, initially, by orthopedic product manufacturers and surgeons. A major RepRegen materials science innovation is the use of Strontium, boosting the performance of the bioceramics.
Company Facts
- Founded: 2006
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.6M
- Last round: Series Unknown (Nov 2010)
- Website: http://www.repregen.com
- Phone: +44 20 7594 1326
Industries & Categories
Biopharma, Biotechnology, Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/repregen-2096707 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.